Radiographic results from the Minocycline in Rheumatoid Arthritis (MIRA) Trial.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Journal of Rheumatology

• Publication date

  1997-07-01

• Fields of study

  Medicine

• Identifiers
  PMID 9228128
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gold salts in the treatment of rheumatoid arthritis. A double-blind study.

  2020cited by this paper
• Radiographic assessment of disease progression in rheumatoid arthritis patients enrolled in the cooperative systematic studies of the rheumatic diseases program randomized clinical trial of methotrexate, auranofin, or a combination of the two.

  1993cited by this paper
• Radiological progression in rheumatoid arthritis: how many patients are required in a treatment trial to test disease modification?

  1993cited by this paper
• The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials.

  1993cited by this paper
• Radiographic evidence of disease progression in methotrexate treated and nonmethotrexate disease modifying antirheumatic drug treated rheumatoid arthritis patients: a meta-analysis.

  1992cited by this paper
• Influence of methotrexate and azathioprine on radiologic progression in rheumatoid arthritis. A randomized, double-blind study.

  1991cited by this paper
• Radiological progression in rheumatoid arthritis: do D-penicillamine and hydroxychloroquine have different effects?

  1990cited by this paper
• Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis.

  1989cited by this paper
• Auranofin improves outcome in early rheumatoid arthritis. Results from a 2-year, double blind placebo controlled study.

  1988cited by this paper
• Low-dose methotrexate compared with azathioprine in the treatment of rheumatoid arthritis. A twenty-four-week controlled clinical trial.

  1987cited by this paper
• Cyclosporin treatment for rheumatoid arthritis: a placebo controlled, double blind, multicentre study.

  1986cited by this paper
• Effects of aurothioglucose and auranofin on radiographic progression in rheumatoid arthritis

  1986cited by this paper
• How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis?

  1985cited by this paper
• Double-blind trial of levamisole, penicillamine and azathioprine in rheumatoid arthritis. Clinical, biochemical, radiological and scintigraphic studies.

  1984cited by this paper
• Radiographic evaluation of erosion in rheumatoid arthritis: double blind study of auranofin vs placebo.

  1984cited by this paper
• Intraclass correlations: uses in assessing rater reliability.

  1979cited by this paper
• Comparison of two dosage schedules of gold salts in the treatment of rheumatoid arthritis. Relationship of serum gold levels to therapeutic response.

  1977cited by this paper
• Clinical evaluation of D-penicillamine by multicentric double-blind comparative study in chronic rheumatoid arthritis.

  1977cited by this paper
• Azathioprine and penicillamine in treatment of rheumatoid arthritis: a controlled trial.

  1976cited by this paper
• Chloroquine in Rheumatoid Arthritis

  1960cited by this paper

• Frequency and risk factor analyses of bone erosion of the distal interphalangeal joint in patients with rheumatoid arthritis: a cross-sectional study.

  2021cites this paper
• Human Microbiota and Autoimmune Diseases

  2019cites this paper
• Separately tackling the development of erosions with denosumab: ultimately closing a gap in the treatment of patients with rheumatoid arthritis or trying too hard too late?

  2016cites this paper
• Minocycline: Rheumatoid Arthritis

  2016cites this paper
• The road forward: the scientific basis for tetracycline treatment of arthritic disorders.

  2011cites this paper
• Dapsone, penicillamine, thalidomide, bucillamine, and the tetracyclines

  2011cites this paper
• CHAPTER 10E – Other Traditional Disease-Modifying Antirheumatic Drugs: Monotherapy and Combination Therapy

  2009cites this paper
• Guidelines for the Use of Conventional and Newer Disease-Modifying Antirheumatic Drugs in Elderly Patients with Rheumatoid Arthritis

  2009cites this paper
• Novel Osteoarthritis Therapeutics

  2007cites this paper
• Reporting of radiographic methods in randomised controlled trials assessing structural outcomes in rheumatoid arthritis

  2006cites this paper
• The frequency and distribution of minocycline induced hyperpigmentation in a rheumatoid arthritis population.

  2006cites this paper
• Matrix metalloproteinases in rheumatoid arthritis

  2004cites this paper
• The significance of serum matrix metalloproteinase 3 in patients with early rheumatoid arthritis

  2004cites this paper
• Patient retention and hand-wrist radiograph progression of rheumatoid arthritis during a 3-year prospective study that prohibited disease modifying antirheumatic drugs.

  2004cites this paper
• The significance of serum matrix metalloproteinase 3 in patients with early rheumatoid arthritis

  2004cites this paper
• The effect of treatment on radiological progression in rheumatoid arthritis: a systematic review of randomized placebo-controlled trials.

  2003cites this paper
• Another DMARD option in rheumatoid arthritis?

  2003cites this paper
• Should tetracycline treatment be used more extensively for rheumatoid arthritis? Metaanalysis demonstrates clinical benefit with reduction in disease activity.

  2003cites this paper
• Practical Prescribing Guidelines for Rheumatoid Arthritis

  2003cites this paper
• Old and New Drugs Used in Rheumatoid Arthritis: A Historical Perspective: Part 2: The Newer Drugs and Drug Strategies

  2001cites this paper
• Lack of effect of doxycycline on disease activity and joint damage in patients with rheumatoid arthritis. A double blind, placebo controlled trial.

  2001cites this paper
• Matrix metalloproteinase inhibitors in rheumatic diseases

  2001cites this paper
• Tetracyclines and autoimmunity

  2001cites this paper
• Biological, non-antibiotic properties of semi-synthetic and chemically modified tetracyclines — a structured, annotated bibliography

  2001cites this paper
• Radiographic assessment of disease progression in rheumatoid arthritis patients treated with methotrexate or minocycline.

  2000cites this paper
• Rheumatology: 8. Advanced therapy.

  2000cites this paper
• An overview of radiographic analysis of joint damage in rheumatoid arthritis and its use in metaanalysis.

  2000cites this paper
• Psoriatic arthritis.

  2000cites this paper
• Assessing radiographic status of rheumatoid arthritis: introduction of a short erosion scale.

  2000cites this paper
• Old and New Drugs Used in Rheumatoid Arthritis: A Historical Perspective

  2000cites this paper
• Tetracyclines for the treatment of rheumatoid arthritis

  2000cites this paper
• Benefits and Risks of Minocycline in Rheumatoid Arthritis

  2000cites this paper
• Antibiotics for the treatment of rheumatologic syndromes.

  1999cites this paper
• Antibiotics for rheumatoid arthritis? Minocycline shows promise in some patients.

  1999cites this paper
• Global statistical tests for comparing multiple outcomes in rheumatoid arthritis trials. MIRA Trial Group.

  1999cites this paper
• Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group.

  1999cites this paper
• A perspective on the use of minocycline for rheumatoid arthritis.

  1999cites this paper
• Minocycline for the treatment of rheumatoid arthritis.

  1998cites this paper